with a detection rate of about 70% (1, 6 and personal data). Most defects are private mutations and few recurrent mutations in unrelated patients probably derived from the presence of a common molecular mechanism rather than a founder effect (7) . The detection of a mutation is associated with the development of the disease and 50% of occurrence in the offspring, thus the genetic test provides a diagnosis together with the possibility of genetic counseling in relatives.
Nevertheless, the molecular determinants of 30% patients still remains unclear and, in the last years, different papers described GNAS epigenetic defects, similar to those classically found in PHP−Ib patients, in a subset of patients with PHP and variable degrees of AHO, suggesting a molecular overlap between PHP1A and PHP1B (8) .
Recently, some cases of PHP1A patients with deletions of 20q, including part or the whole GNAS gene, and an inversion at GNAS were reported, demonstrating that chromosomal rearrangements may also cause PHP1A and that investigation for these less common genetic defects is needed (9) . Moreover, deletions ablating GNAS DMRs mimic an imprinting defect during the methylation analysis and may lead to a misdiagnosis of PHP1B (10). These defects, undetectable by Sanger sequencing and often also by karyotype investigation, are considered clearly distinct from the smallscale gene mutations, both for the size of the rearranged DNA and the underlying formation mechanisms (11, 12) .
In order to ameliorate molecular diagnostic and genetic counseling, the aims of our work were to identify and characterize novel GNAS locus defects, such as microdeletions or -duplications, associated with PHP1A/PPHP using methylation specificmultiplex ligation-dependent probe amplification (MS-MLPA) and custom made CGH array and unravel putative molecular mechanisms responsible for these rearrangements.
PATIENTS AND METHODS
A total of 112 patients with PHP1A/PPHP phenotype and no GNAS mutations, all born from non-consanguineous parents, were studied. The clinical diagnosis was based upon the presence of at least two of the six AHO manifestations: brachydactyly (shortening of fourth and/or fifth metacarpals), short stature (height below the 3th percentile for chronological age), obesity (BMI >30 kg/m 2 in adults and >97 th centile in children), round face, subcutaneous ossifications (either clinically evident or at X-ray), and mental retardation; when these signs were observed in the presence of PTH resistance (i.e.
hypocalcemia, hyperphosphatemia and raised serum PTH levels), PHP1A diagnosis was made. All PHP1A patients showed also resistance to TSH, documented by raised serum TSH levels, absence of anti-thyroid antibodies and presence of a normal thyroid scan.
Patients were studied in different labs, using different techniques. A detailed description of methods is provided as supplementary data (point 1, Supp. Table 1 ). Informed consent was obtained from all patients and relatives included in the study.
RESULTS
Allele dosage and methylation analysis by MS-MLPA or custom aCGH revealed the presence of 7 heterozygous deletions of part or whole GNAS locus, ranging from 106-bp to 2.6-Mb, in a cohort of 112 GNAS point mutation-negative PHP1A/PPHP probands (detection rate 6.25%).
Six of the seven patients (2 females and 4 males) were affected by PHP1A, and one female patient by PPHP (patient #6). When possible, the parental origin of the deletion was identified and the whole family studied. Main clinical features of deleted patients and affected relatives are described in Table 1 . A comprehensive description of novel rearrangements is available in the supplementary data section 2 ( Figure 1A /B).
Deletions' breakpoints were subjected to bioinformatic analyses to explore underlying mechanisms and to assess the contribution of the genomic architecture. We analyzed the extent of microhomology at breakpoints and investigated for the presence of known sequence motifs, purine-pyrimidine repeats, AT-content and repetitive elements. An overview of all these results can be found in supplementary data point 3 (Supp. Table 2) .
DISCUSSION
In about 70% of cases, PHP1A/PPHP are due to haploinsufficiency caused by maternally/paternally-inherited heterozygous inactivating mutations of the GNAS gene (1, 6) . A subset of patients not carrying mutations in GNAS coding exons might have a deletion removing the entire or part of the GNAS gene. Constitutional aberrations of the long arm of chromosome 20 are quite rare, and, to our knowledge, only 7 cases with an interstitial chromosome 20q deletion including GNAS have been described in the literature so far (9, 10, 13 -15).
Here, we report 1 PPHP and 6 PHP1A patients with different submicroscopic deletions including part or the whole GNAS locus. Accordingly, we describe novel deletions in 7/112 probands (6.25%), confirming that these events represent a significant cause of PPHP/PHP1A, and that, although undetectable by standard PCR-based sequencing, they can be clearly identified by aCGH or MS-MLPA.
For a subset of PHP patients, for whom no mutations are identified by GNAS coding region sequencing, the presence of a deletion should be considered for a proper genetic counseling. Indeed, some patients studied for the presence of imprinting defects by methylation-quantitative techniques could be misdiagnosed as PHP1B patients, as previously indicated (10) and now confirmed by patients #1 and #5 of the present work.
Unfortunately, a deep phenotypic characterization does not allow to clearly identify a priori the causative molecular defect.
Our findings suggest that some clinical features, namely mental retardation, short stature, round face, brachydactyly, subcutaneous ossifications, are common to most patients, as expected by the removal of GNAS Gsα-coding exons. As for the PHP1A phenotype in particular, in accordance with previously reported series showing no genotype/phenotype correlation in this disease (7, 16) , in this cohort there is no apparent clinical difference between patients with point mutations and those with GNAS deletions. Moreover, as described for point mutations, intrafamilial differences in phenotypic expression can also be found in those with GNAS rearrangements and be not only associated to the imprinting effect (family #2 and #7 of the present report, 13).
Hyperinsulinemia, namely reduced insulin sensitivity, and type 2 diabetes have been recently identified as an additional feature of adult PHP1A (17) . On the contrary, complex phenotypes (attention deficit disorder, Evans syndrome, cirrhosis, psoriasis, asthma and bilateral adrenal hyperplasia) may result from a contiguous gene deletion syndrome, as they are hardly explained by GNAS haploinsufficiency alone. We compared our cases with those previously described by 2 other groups and determined the smallest region of overlap (SRO) among deletions, in order to unveil genes contributing to common and, symmetrically, patient-specific clinical features (9, 1528) (Supp. Figure 1 ). Patients with a paternal deletion suffered from pre-and post-natal severe growth retardation, dysmorphism, hypotonia and feeding difficulties, but no further similarities can be deduced as 2 cases, with no typical AHO phenotype, were too young and could have developed other signs over the time. As for maternal deletions, there aren't significant differences in involved genes that might explain the reported clinical differences. However, the number of patients with large deletions is too small to speculate the contribution of specific adjacent genes in determining complex phenotypes.
Single or multi-exon rearrangements in GNAS can be routinely screened by MS-MLPA or aCGH (10, 18). However, these diagnostic techniques do not provide detailed information on breakpoints location, so different deletions involving the same exon(s) cannot be distinguished, nor can insight be acquired into the developmental mechanism of these rearrangements. Therefore, we have molecularly characterized the precise deletion boundaries in 5 of the 7 probands and hypothesized the developmental mechanism of these rearrangements.
Genomic deletions can occur during the repair of DNA double strand breaks (DSB's) by several mechanisms: (i) non-replicative repair mechanisms: non-homologous endjoining (NHEJ) or non-allelic homologous recombination (NAHR) and (ii) replicativebased repair mechanisms (19) .
The major DNA-repair mechanism in humans is NHEJ, either classical with short terminal microhomologies of no more than 4 bp, or non-classical (microhomologymediated end-joining -MMEJ). The insertion of additional bases at the breakpoint junction, as in patient #7, is a phenomenon associated to classical NHEJ, which is thus one potential mechanism for this deletion (19) .
NAHR, the most common mechanism underlying disease-associated genomic rearrangements and recurrent deletions, occurs between nonallelic homologous sequences, generally repetitive elements of at least 200-bp, such as long or short interspersed nuclear elements (LINE's or SINE's, including Alu-elements) or low copy repeats (LCR's). Diverse studies demonstrated that an high content of Alu-elements results in increased frequency of gene disruption by large deletions in several human diseases, also called Alu-recombination mediated deletion (ARMD)-events (20) . We analyzed the regions deleted in our patients for the presence of any of these elements and we found repetitive elements of the same family at both breakpoints in 4 cases (patient #1, #2, #6 and #7), which could indicate NAHR as causative mechanism.
Therefore, an Alu-mediated NAHR might result in deletions of patients #2, #6 and #7, while patient #1 showed LINE2 elements at proximal and distal breakpoint junctions.
Alternative mechanisms (NHEJ) appear to be involved in patient #4 deletion, as no repetitive elements were found in the proximity of the breakpoints. The most plausible cause for the deletion of patient #1 is a replicative-based repair mechanism, even though the presence of 2-bp microhomology at the breakpoint junction and deletion-associated DNA sequence motif at the proximal region could also be consistent with classical NHEJ.
Overall, although each deletion event appears to be unique, Alu sequences play a major role in determining the instability of the region. Regardless of the specific recombination mechanism, genomic architectural features have been associated with many rearrangement breakpoints. This suggests that chromosomal rearrangements are not random events, but result from a predisposition due to the existence of a complex underlying genomic architecture that may create instability in the genome.
In conclusion, our data confirm that GNAS deletions must be considered as a possible and significant cause of PPHP/PHP1A. In order to avoid misdiagnosis with PHP1B and to determine the recurrence risk in the offspring, patients negative for point mutations should be further investigated for such rare genetic defects. . Age 1 refers to the age at molecular diagnosis, while age 2 is the one at clinical diagnosis. PTH and TSH levels refer to the ones at clinical diagnosis, normal values: 10-65 pg/mL for PTH and 0.2-4.0 mUI/L for TSH (unknown levels for patients 4&5 in whom a neonatal diagnosis of primary hypothyroidism was made).
DETAILED DESCRIPTION OF MOLECULAR BIOLOGY TECHNIQUES APPLIED TO UNRAVEL AND CHARACTERIZE GNAS STRUCTURAL REARRANGEMENTS IN OUR SERIES

GNAS locus MS-MLPA analysis
Dosage of allele segments and methylation analyses of GNAS locus were carried out by MS-MLPA using the SALSA MLPA ME031 GNAS probemix (MRC-Holland, Amsterdam, The Netherlands) and ABI3130xl and ABI3500 Genetic Analyzers (Perkin-Elmer Corp.), as previously described (S1, S2). Data analysis was performed using GeneMapper software (Applied Biosystems, Foster City, CA) and Coffalyser v9.4 (MRC-Holland, Amsterdam, The Netherlands). A probe ratio below 0.7 for different consecutive probes was considered suggestive of a heterozygous deletion.
Genome-wide SNParray
An Illumina Human660W-Quad BeadChip was run for patients #1 and #5. This array includes 657,366 markers distributed evenly across the genome, with 14,854 markers located on chromosome 20. Images were analyzed using the Chromosome Viewer tool contained in Genome Studio (Illumina, San Diego, CA, USA). Genomic build NCBI37 (Hg19) was used for the experiments.
Custom CGHarray
Boundaries' delimitation
As a first step toward the delimitation of deletions, different methods for semiquantitative amplifications were used.
Semiquantitative PCR (sq-PCR)
Semiquantitative amplification of specific sequences (about 100-bp length) surrounding the region found deleted by MS-MLPA was performed (primers available upon request). Briefly, serial dilutions of wild-type DNA were amplified by non-saturated PCR (20 cycles) together with patients DNA and, after agarose electrophoresis, were analyzed by densitometric scanning of photographs of gels with ImageJ software.
Alternatively, semiquantitative multiplex PCR of short fluorescent fragments (QMPSF) was employed. Firstly, we designed diverse PCR fragments for each flanking region. In the 5'flanking region the reverse primer was marked with fluorescence, whilst in the 3'flanking region the marked primer was forward. These PCRs were performed vs. a known 2 copies region of the genome (as control region) to get a relative semiquantitative PCR (stopped at exponential phase). After the multiplex reaction, the DNA fragments were separated on an ABI3500 Genetic Analyzer and analyzed using GeneMapper software (Applied Biosystems).
To calculate allele dosage we used the numerical sample-to-control comparison. We calculated numerical normalized ratios (R) using the formula: R=(peak intensityamplicon x sample/peak intensityamplicon x control)/(peak intensityamplicon ref sample/peak intensityamplicon ref control). An R value close to 0.5 (0.4-0.6) represented a 2-fold reduction. As a result we found regions that were located inside the deletion (PCR relative ratio~0.5) and other regions that were located outside the deletion (PCR relative ratio~1). The objective was to approach as much as possible to the deletion, for the purpose of obtaining a large PCR of the deleted allele and sequences it to identify the breakpoints. This final PCR was run with the nearest to the deletion forward unlabeled primer of the 5'falnking region (in which two copies were observed) and the nearest to the deletion unlabeled reverse of the 3'flanking region (conditions and primers available upon request).
Then, to locate breakpoints at nucleotide level, long range PCRs with primers flanking deleted sequences and a highly performing proofreading polymerase, LA Taq DNA Polymerase (Takara Bio Inc., Otsu, Japan), were performed (conditions and primers available upon request).
Finally, amplicons from deleted alleles were excised from agarose gel after electrophoretic separation, extracted with the MinElute Gel Extraction kit (Qiagen, Hilden, Germany) and sequenced.
Parental origin of deletions
When possible, deletion's parental origin was determined either by long-PCR crossing the boundaries, by microsatellite markers analysis or deduced by the methylation status obtained by MS-MLPA. Three microsatellites were genotyped by migration of the fluorescent-labelled PCR products on a 3130xl Genetic Analyzer (AppliedBiosystems), a 18AC repeat (g.58,304,592-g.58,304,928) localized at the 5' end of the GNAS locus, a 28AC repeat (g.58,439,667-g.58,440,096) within the GNAS locus, and a 19AC repeat (g.58,529,668-g.58,530,005) localized at the 3' end of the GNAS locus.
In silico analysis of breakpoint regions
Breakpoint regions and junction fragments were subjected to an extensive bioinformatic analysis to assess the involvement of the genomic architecture in the origin of the deletions as previously described (S3).
DETAILED DESCRIPTION OF NOVEL GNAS STRUCTURAL REARRANGEMENTS IDENTIFIED IN OUR SERIES
Short deletions
Defects detected in patients #2, #3, #4 and #7 were short GNAS deletions, affecting only one to seven Gsα-coding exons. The methylation analysis confirmed the absence of imprinting defects for patients #2, #4 and #7.
MS-MLPA investigation of sisters #2a and #2b led to the hypothesis of a deletion encompassing, at least GNAS exons from 7 to 13. Breakpoint characterization and parent's analysis confirmed a maternally-inherited interstitial deletion of 5,842-bp at genomic location g.57,482,794_57,488,635, according to the Genome Reference Consortium Human Build 37 (GRCh37) ( Figure 1A ). Their mother (#2m) presented only short stature with normal serum calcium, phosphorous and PTH levels. 
Long deletions
Deletions found in patients #1, #5 and #6 comprised the entire GNAS locus.
Methylation analysis of patients #1 and #5 displayed a pattern of loss of imprinting 
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